Jim Cramer Reports That Moderna, Inc. (MRNA) Was ‘Down Nearly 44% In The Third Quarter’
We recently compiled a list of the Jim Cramer’s List of Stocks that Finished Dead Last. In this article, we are going to take ...
Is Moderna, Inc. (MRNA) the Worst Performing Stock to Buy on the Dip?
We recently compiled a list of 10 Worst Performing Stocks to Buy on the Dip. In this article, we will look at where Moderna, ...
Moderna Inc (NASDAQ:MRNA): Jim Cramer Is Disappointed
We recently published a list of Jim Cramer’s Latest Portfolio: Top 9 Stocks to Buy and Sell. Since Moderna Inc (NASDAQ:MRNA) ...
Nasdaq3d
MRNA November 22nd Options Begin Trading
Investors in Moderna Inc (Symbol: MRNA) saw new options begin trading today, for the November 22nd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRNA ...
Nasdaq2d
Notable Friday Option Activity: MRNA, BILL, VKTX
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Moderna Inc (Symbol: MRNA), where a total of 32,193 contracts have traded so far ...
Nasdaq12d
Moderna (MRNA) Stock Slides as Market Rises: Facts to Know Before You Trade
Moderna (MRNA) closed at $63.94 in the latest trading ... At the same time, the Dow added 0.2%, and the tech-heavy Nasdaq gained 0.56%. The biotechnology company's stock has dropped by 21.46% ...
Nasdaq6d
Moderna (MRNA) Rises Higher Than Market: Key Facts
Moderna (MRNA) closed at $66.83 in the latest trading ... Meanwhile, the Dow experienced a rise of 0.04%, and the technology-dominated Nasdaq saw an increase of 0.38%. Coming into today, shares ...
TMCnet1d
MRNA Deadline: Rosen Law Firm Urges Moderna, Inc. (NASDAQ: MRNA) Stockholders With Large Losses to Contact the Firm for Information About Their Rights
For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Allegations that Moderna, Inc. (NASDAQ: MRNA) ...
Alnylam's Concedes Its Patent Infringement Case Against Moderna's COVID-19 Vaccine
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) and Moderna, Inc. (NASDAQ:MRNA) have reached a stipulation in their ongoing ...
Nasdaq7d
Self-Amplifying mRNA COVID-19 Vaccine Demonstrates Superior Immune Response Compared with mRNA Vaccine at 12 Months Post-Vaccination
About ArcturusFounded in 2013 and based in San Diego, California, Arcturus Therapeutics Holdings Inc. (Nasdaq: ARCT) is a global mRNA medicines and vaccines company with enabling technologies: (i ...
Nasdaq7d
Self-Amplifying mRNA COVID-19 Vaccine Demonstrates Superior Immune Response Compared with mRNA Vaccine at 12 Months Post-Vaccination
Head-to-head data, presented at OPTIONS XII for the Control of Influenza Conference, demonstrates advantage of sa-mRNA over conventional mRNA in duration of immune response; Results highlight CSL ...